Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Frustration Over English Funding Rejection For Zytiga And A Win For Ledaga
Zyntiga Decision 'Highlights Need For Innovative Pricing Models'
Jul 20 2021
•
By
Neena Brizmohun
NICE has said no to funding for Zytiga for newly diagnosed, advanced prostate cancer • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Market Access
More from Pink Sheet